1
|
Hatori A, Yamakawa D, Al-Maawi S, Dohle E, Chikira J, Fujii Y, Miki M, Sader R, Chikazu D, Ghanaati S, Kawase-Koga Y. Platelet-Rich Fibrin-Conditioned Medium as an Alternative to Fetal Bovine Serum Promotes Osteogenesis of Human Dental Pulp Stem Cells. Bioengineering (Basel) 2023; 10:1196. [PMID: 37892927 PMCID: PMC10604799 DOI: 10.3390/bioengineering10101196] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/20/2023] [Revised: 10/09/2023] [Accepted: 10/10/2023] [Indexed: 10/29/2023] Open
Abstract
Human dental pulp stem cells (DPSCs) exhibit multilineage differentiation capabilities and superior clonogenic and proliferative properties. However, the use of animal-derived components such as FBS raises concerns regarding the clinical application of stem-cell-based therapies. Platelet-rich fibrin (PRF) derived from human blood is rich in fibrin, platelets, and growth factors and acts as a bioactive scaffold for grafting with biomaterials. In this study, we assessed the efficacy of PRF-conditioned medium (CM) in promoting DPSCs proliferation and osteogenic differentiation compared with the standard culture medium supplemented with FBS. A comparison of DPSCs cultured in FBS and PRF-CM revealed no differences in characteristics or morphology. However, cells cultured with PRF-CM exhibited inferior proliferation rates and cell numbers during passage in comparison with those cultured with FBS. In contrast, DPSCs cultured in PRF-CM showed significantly higher levels of calcification, and RT-PCR confirmed that the gene expression levels of markers associated with osteoblast differentiation were significantly increased. The PRF-CM approach offers a convenient, straightforward, and advantageous method for culturing DPSCs, without relying on animal-derived components. In summary, this study introduces a novel application of PRF-CM for enhancing the osteogenesis of DPSCs, which provides an alternative to FBS culture medium and addresses concerns associated with the use of animal-derived components in clinical settings.
Collapse
Affiliation(s)
- Ayano Hatori
- Department of Oral and Maxillofacial Surgery, Tokyo Medical University, 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo 160-0023, Japan; (A.H.); (D.Y.); (J.C.); (Y.F.); (M.M.); (D.C.)
| | - Daiki Yamakawa
- Department of Oral and Maxillofacial Surgery, Tokyo Medical University, 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo 160-0023, Japan; (A.H.); (D.Y.); (J.C.); (Y.F.); (M.M.); (D.C.)
| | - Sarah Al-Maawi
- FORM, Frankfurt Oral Regenerative Medicine, Clinic for Maxillofacial and Plastic Surgery, Goethe University, Theodor-Stern-Kai 7, 60596 Frankfurt, Germany (E.D.); (R.S.); (S.G.)
| | - Eva Dohle
- FORM, Frankfurt Oral Regenerative Medicine, Clinic for Maxillofacial and Plastic Surgery, Goethe University, Theodor-Stern-Kai 7, 60596 Frankfurt, Germany (E.D.); (R.S.); (S.G.)
| | - Jin Chikira
- Department of Oral and Maxillofacial Surgery, Tokyo Medical University, 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo 160-0023, Japan; (A.H.); (D.Y.); (J.C.); (Y.F.); (M.M.); (D.C.)
| | - Yasuyuki Fujii
- Department of Oral and Maxillofacial Surgery, Tokyo Medical University, 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo 160-0023, Japan; (A.H.); (D.Y.); (J.C.); (Y.F.); (M.M.); (D.C.)
| | - Megumu Miki
- Department of Oral and Maxillofacial Surgery, Tokyo Medical University, 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo 160-0023, Japan; (A.H.); (D.Y.); (J.C.); (Y.F.); (M.M.); (D.C.)
| | - Robert Sader
- FORM, Frankfurt Oral Regenerative Medicine, Clinic for Maxillofacial and Plastic Surgery, Goethe University, Theodor-Stern-Kai 7, 60596 Frankfurt, Germany (E.D.); (R.S.); (S.G.)
| | - Daichi Chikazu
- Department of Oral and Maxillofacial Surgery, Tokyo Medical University, 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo 160-0023, Japan; (A.H.); (D.Y.); (J.C.); (Y.F.); (M.M.); (D.C.)
| | - Shahram Ghanaati
- FORM, Frankfurt Oral Regenerative Medicine, Clinic for Maxillofacial and Plastic Surgery, Goethe University, Theodor-Stern-Kai 7, 60596 Frankfurt, Germany (E.D.); (R.S.); (S.G.)
| | - Yoko Kawase-Koga
- Department of Oral and Maxillofacial Surgery, Tokyo Medical University, 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo 160-0023, Japan; (A.H.); (D.Y.); (J.C.); (Y.F.); (M.M.); (D.C.)
- Division of Maxillofacial Surgery and Stomatology, Department of Oral and Maxillofacial Surgery, School of Medicine, Tokyo Women’s Medical University, 8-1 Kawadachou, Shinjuku-ku, Tokyo 162-8666, Japan
| |
Collapse
|
2
|
Kang JY, Oh MK, Joo H, Park HS, Chae DH, Kim J, Lee HR, Oh IH, Yu KR. Xeno-Free Condition Enhances Therapeutic Functions of Human Wharton's Jelly-Derived Mesenchymal Stem Cells against Experimental Colitis by Upregulated Indoleamine 2,3-Dioxygenase Activity. J Clin Med 2020; 9:jcm9092913. [PMID: 32927587 PMCID: PMC7565923 DOI: 10.3390/jcm9092913] [Citation(s) in RCA: 13] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/30/2020] [Accepted: 09/05/2020] [Indexed: 12/15/2022] Open
Abstract
The therapeutic applications of mesenchymal stem cells (MSCs) have been actively explored due to their broad anti-inflammatory and immunomodulatory properties. However, the use of xenogeneic components, including fetal bovine serum (FBS), in the expansion media might pose a risk of xenoimmunization and zoonotic transmission to post-transplanted patients. Here, we extensively compared the physiological functions of human Wharton’s jelly-derived MSCs (WJ-MSCs) in a xeno-free medium (XF-MSCs) and a medium containing 10% FBS (10%-MSCs). Both groups showed similar proliferation potential; however, the 10%-MSCs showed prolonged expression of CD146, with higher colony-forming unit-fibroblast (CFU-F) ability than the XF-MSCs. The XF-MSCs showed enhanced adipogenic differentiation potential and sufficient hematopoietic stem cell (HSC) niche activity, with elevated niche-related markers including CXCL12. Furthermore, we demonstrated that the XF-MSCs had a significantly higher suppressive effect on human peripheral blood-derived T cell proliferation, Th1 and Th17 differentiation, as well as naïve macrophage polarization toward an M1 phenotype. Among the anti-inflammatory molecules, the production of indoleamine 2,3-dioxygenase (IDO) and nitric oxide synthase 2 (NOS2) was profoundly increased, whereas cyclooxygenase-2 (COX-2) was decreased in the XF-MSCs. Finally, the XF-MSCs had an enhanced therapeutic effect against mouse experimental colitis. These findings indicate that xeno-free culture conditions improved the immunomodulatory properties of WJ-MSCs and ex vivo-expanded XF-MSCs might be an effective strategy for preventing the progression of colitis.
Collapse
Affiliation(s)
- Ji Yeon Kang
- Department of Medical Life Sciences, College of Medicine, The Catholic University of Korea, Seoul 08826, Korea; (J.Y.K.); (M.-K.O.); (H.J.); (H.S.P.); (D.-H.C.); (J.K.)
| | - Mi-Kyung Oh
- Department of Medical Life Sciences, College of Medicine, The Catholic University of Korea, Seoul 08826, Korea; (J.Y.K.); (M.-K.O.); (H.J.); (H.S.P.); (D.-H.C.); (J.K.)
| | - Hansol Joo
- Department of Medical Life Sciences, College of Medicine, The Catholic University of Korea, Seoul 08826, Korea; (J.Y.K.); (M.-K.O.); (H.J.); (H.S.P.); (D.-H.C.); (J.K.)
| | - Hyun Sung Park
- Department of Medical Life Sciences, College of Medicine, The Catholic University of Korea, Seoul 08826, Korea; (J.Y.K.); (M.-K.O.); (H.J.); (H.S.P.); (D.-H.C.); (J.K.)
| | - Dong-Hoon Chae
- Department of Medical Life Sciences, College of Medicine, The Catholic University of Korea, Seoul 08826, Korea; (J.Y.K.); (M.-K.O.); (H.J.); (H.S.P.); (D.-H.C.); (J.K.)
| | - Jieun Kim
- Department of Medical Life Sciences, College of Medicine, The Catholic University of Korea, Seoul 08826, Korea; (J.Y.K.); (M.-K.O.); (H.J.); (H.S.P.); (D.-H.C.); (J.K.)
- Futuristic Animal Resource & Research Center, Korea Research Institute of Bioscience and Biotechnology, Chungcheongbuk-do 28116, Korea
| | - Hae-Ri Lee
- Catholic High-Performance Cell Therapy Center & Department of Medical Life Science, College of Medicine, The Catholic University, Seoul 08826, Korea;
| | - Il-Hoan Oh
- Catholic High-Performance Cell Therapy Center & Department of Medical Life Science, College of Medicine, The Catholic University, Seoul 08826, Korea;
- Correspondence: (I.-H.O.); (K.-R.Y.)
| | - Kyung-Rok Yu
- Department of Medical Life Sciences, College of Medicine, The Catholic University of Korea, Seoul 08826, Korea; (J.Y.K.); (M.-K.O.); (H.J.); (H.S.P.); (D.-H.C.); (J.K.)
- Department of Agricultural Biotechnology and Research Institute of Agriculture and Life Sciences, Seoul National University, Seoul 08826, Korea
- Correspondence: (I.-H.O.); (K.-R.Y.)
| |
Collapse
|
3
|
Palamà MEF, Shaw GM, Carluccio S, Reverberi D, Sercia L, Persano L, Pisignano D, Cortese K, Barry FP, Murphy JM, Gentili C. The Secretome Derived From Mesenchymal Stromal Cells Cultured in a Xeno-Free Medium Promotes Human Cartilage Recovery in vitro. Front Bioeng Biotechnol 2020; 8:90. [PMID: 32117953 PMCID: PMC7033421 DOI: 10.3389/fbioe.2020.00090] [Citation(s) in RCA: 19] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/03/2019] [Accepted: 01/30/2020] [Indexed: 01/06/2023] Open
Abstract
Osteoarthritis (OA) is a disabling joint disorder causing articular cartilage degeneration. Currently, the treatments are mainly aimed to pain and symptoms relief, rather than disease amelioration. Human bone marrow stromal cells (hBMSCs) have emerged as a promising paracrine mechanism-based tool for OA treatment. Here, we investigate the therapeutic potential of conditioned media (CM) and extracellular vesicles (EVs) isolated from hBMSC and grown in a xeno-free culture system (XFS) compared to the conventional fetal bovine serum-culture system (FBS) in an in vitro model of OA. First, we observed that XFS promoted growth and viability of hBMSCs compared to FBS-containing medium while preserving their typical phenotype. The biological effects of the CM derived from hBMSC cultivated in XFS- and FBS-based medium were tested on IL-1α treated human chondrocytes, to mimic the OA enviroment. Treatment with CM derived from XFS-cultured hBMSC inhibited IL-1α-induced expression of IL-6, IL-8, and COX-2 by hACs compared to FBS-based condition. Furthermore, we observed that hBMSCs grown in XFS produced a higher amount of EVs compared to FBS-culture. The hBMSC-EVs not only inhibit the adverse effects of IL-1α-induced inflammation, but play a significant in vitro chondroprotective effect. In conclusion, the XFS medium was found to be suitable for isolation and expansion of hBMSCs with increased safety profile and intended for ready-to-use clinical therapies.
Collapse
Affiliation(s)
| | | | - Simonetta Carluccio
- Laboratory of Cellular Oncology, Department of Experimental Medicine, University of Genoa, Genoa, Italy
| | - Daniele Reverberi
- U.O. Molecular Pathology, IRCCS Ospedale Policlinico San Martino, Genoa, Italy
| | - Laura Sercia
- Institute of Nanoscience (CNR-NANO), Pisa, Italy
| | | | - Dario Pisignano
- Institute of Nanoscience (CNR-NANO), Pisa, Italy.,Department of Physics, University of Pisa, Pisa, Italy
| | - Katia Cortese
- Department of Experimental Medicine, Human Anatomy, University of Genoa, Genoa, Italy
| | - Francis Peter Barry
- Regenerative Medicine Institute, National University of Ireland Galway, Galway, Ireland
| | - Josephine Mary Murphy
- Regenerative Medicine Institute, National University of Ireland Galway, Galway, Ireland
| | - Chiara Gentili
- Laboratory of Cellular Oncology, Department of Experimental Medicine, University of Genoa, Genoa, Italy
| |
Collapse
|
4
|
Mazzoni S, Mohammadi S, Tromba G, Diomede F, Piattelli A, Trubiani O, Giuliani A. Role of Cortico-Cancellous Heterologous Bone in Human Periodontal Ligament Stem Cell Xeno-Free Culture Studied by Synchrotron Radiation Phase-Contrast Microtomography. Int J Mol Sci 2017; 18:ijms18020364. [PMID: 28208578 PMCID: PMC5343899 DOI: 10.3390/ijms18020364] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/17/2016] [Revised: 01/24/2017] [Accepted: 02/03/2017] [Indexed: 01/01/2023] Open
Abstract
This study was designed to quantitatively demonstrate via three-dimensional (3D) images, through the Synchrotron Radiation Phase-Contrast Microtomography (SR-PhC-MicroCT), the osteoinductive properties of a cortico-cancellous scaffold (Osteobiol Dual Block—DB) cultured with human Periodontal Ligament Stem Cells (hPDLSCs) in xeno-free media. In vitro cultures of hPDLSCs, obtained from alveolar crest and horizontal fibers of the periodontal ligament, were seeded onto DB scaffolds and cultured in xeno-free media for three weeks. 3D images were obtained by SR-PhC-microCT after one and three weeks from culture beginning. MicroCT data were successively processed with a phase-retrieval algorithm based on the Transport of Intensity Equation (TIE). The chosen experimental method, previously demonstratively applied for the 3D characterization of the same constructs in not xeno-free media, quantitatively monitored also in this case the early stages of bone formation in basal and differentiating conditions. Interestingly, it quantitatively showed in the xeno-free environment a significant acceleration of the mineralization process, regardless of the culture (basal/differentiating) medium. This work showed in 3D that the DB guides the osteogenic differentiation of hPDLSCs in xeno-free cultures, in agreement with 2D observations and functional studies previously performed by some of the authors. Indeed, here we fully proved in 3D that expanded hPDLSCs, using xeno-free media formulation, not only provide the basis for Good Manufacturing Practice (preserving the stem cells’ morphological features and their ability to differentiate into mesenchymal lineage) but have to be considered, combined to DB scaffolds, as interesting candidates for potential clinical use in new custom made tissue-engineered constructs.
Collapse
Affiliation(s)
- Serena Mazzoni
- Department of Clinical Sciences-Unit of Biochemistry, Biology and Physics, Polytechnic University of Marche, Via Brecce Bianche 1, 60131 Ancona, Italy.
| | - Sara Mohammadi
- Sincrotrone Trieste S.C.p.A., Strada Statale 14 km 163.5 in AREA Science Park, 34149 Trieste, Italy.
| | - Giuliana Tromba
- Sincrotrone Trieste S.C.p.A., Strada Statale 14 km 163.5 in AREA Science Park, 34149 Trieste, Italy.
| | - Francesca Diomede
- Department of Medical, Oral and Biotechnological Sciences, University of Chieti-Pescara, 66100 Chieti, Italy.
| | - Adriano Piattelli
- Department of Medical, Oral and Biotechnological Sciences, University of Chieti-Pescara, 66100 Chieti, Italy.
| | - Oriana Trubiani
- Department of Medical, Oral and Biotechnological Sciences, University of Chieti-Pescara, 66100 Chieti, Italy.
| | - Alessandra Giuliani
- Department of Clinical Sciences-Unit of Biochemistry, Biology and Physics, Polytechnic University of Marche, Via Brecce Bianche 1, 60131 Ancona, Italy.
| |
Collapse
|